Integral Health Asset Management 13F annual report
Integral Health Asset Management is an investment fund managing more than $1 trillion ran by John Virginia. There are currently 69 companies in Mr. Virginia’s portfolio. The largest investments include Insmed Inc and Tenet Healthcare, together worth $170 billion.
$1 trillion Assets Under Management (AUM)
As of 7th August 2024, Integral Health Asset Management’s top holding is 1,550,000 shares of Insmed Inc currently worth over $104 billion and making up 10.3% of the portfolio value.
Relative to the number of outstanding shares of Insmed Inc, Integral Health Asset Management owns more than approximately 0.1% of the company.
In addition, the fund holds 500,000 shares of Tenet Healthcare worth $66.5 billion, whose value grew 72.3% in the past six months.
The third-largest holding is Cytokinetics Inc worth $54.2 billion and the next is Boston Scientific worth $50.1 billion, with 650,000 shares owned.
Currently, Integral Health Asset Management's portfolio is worth at least $1 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Integral Health Asset Management
The Integral Health Asset Management office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, John Virginia serves as the Chief Compliance Officer at Integral Health Asset Management.
Recent trades
In the most recent 13F filing, Integral Health Asset Management revealed that it had opened a new position in
Becton Dickinson & Co and bought 75,000 shares worth $17.5 billion.
This means they effectively own approximately 0.1% of the company.
Becton Dickinson & Co makes up
2.3%
of the fund's Health Care sector allocation and has decreased its share price by 16.4% in the past year.
The investment fund also strengthened its position in Insmed Inc by buying
250,000 additional shares.
This makes their stake in Insmed Inc total 1,550,000 shares worth $104 billion.
Insmed Inc soared 242.5% in the past year.
On the other hand, there are companies that Integral Health Asset Management is getting rid of from its portfolio.
Integral Health Asset Management closed its position in Walgreens Boots Alliance Inc on 14th August 2024.
It sold the previously owned 1,300,000 shares for $28.2 billion.
John Virginia also disclosed a decreased stake in Encompass Health Corp by 0.1%.
This leaves the value of the investment at $25.7 billion and 300,000 shares.
One of the average hedge funds
The two most similar investment funds to Integral Health Asset Management are Sir Capital Management, L.P. and Paradigm Operations L.P.. They manage $1.01 trillion and $1 trillion respectively.
John Virginia investment strategy
Integral Health Asset Management’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 77.2% of
the total portfolio value.
The fund focuses on investments in the United States as
65.2% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
26% of the total holdings value.
On the other hand, small-cap stocks make up only 1.4% of the portfolio.
The average market cap of the portfolio companies is close to $32.7 billion.
The complete list of Integral Health Asset Management trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Insmed Inc |
19.23%
1,550,000
|
$103,850,000,000 | 10.34% |
| Tenet Healthcare Corp. |
17.65%
500,000
|
$66,515,000,000 | 6.62% |
| Cytokinetics Inc |
122.22%
1,000,000
|
$54,180,000,000 | 5.39% |
| Boston Scientific Corp. |
8.33%
650,000
|
$50,056,500,000 | 4.98% |
| Elevance Health Inc |
60.00%
80,000
|
$43,348,800,000 | 4.31% |
| Blueprint Medicines Corp |
61.90%
340,000
|
$36,645,200,000 | 3.65% |
| Novartis AG |
33.33%
300,000
|
$31,938,000,000 | 3.18% |
| Longboard Pharmaceuticals In |
12.82%
1,100,000
|
$29,733,000,000 | 2.96% |
| Merck & Co Inc |
No change
235,000
|
$29,093,000,000 | 2.90% |
| Walgreens Boots Alliance Inc |
Closed
1,300,000
|
$28,197,000,000 | |
| Humana Inc. |
25.00%
75,000
|
$28,023,750,000 | 2.79% |
| Encompass Health Corp |
14.29%
300,000
|
$25,737,000,000 | 2.56% |
| Abbvie Inc |
Closed
135,000
|
$24,583,500,000 | |
| Universal Hlth Svcs Inc |
4.00%
130,000
|
$24,040,900,000 | 2.39% |
| Inari Med Inc |
100.00%
400,000
|
$19,260,000,000 | 1.92% |
| Vera Therapeutics Inc |
38.89%
500,000
|
$18,090,000,000 | 1.80% |
| Crinetics Pharmaceuticals In |
23.08%
400,000
|
$17,916,000,000 | 1.78% |
| Charles Riv Labs Intl Inc |
Closed
65,000
|
$17,611,750,000 | |
| Becton Dickinson & Co. |
Opened
75,000
|
$17,528,250,000 | 1.74% |
| Cigna Group (The) |
25.00%
50,000
|
$16,528,500,000 | 1.65% |
| Regeneron Pharmaceuticals, Inc. |
Closed
17,000
|
$16,362,330,000 | |
| Tarsus Pharmaceuticals, Inc. |
No change
590,000
|
$16,036,200,000 | 1.60% |
| Penumbra Inc |
Closed
70,000
|
$15,622,600,000 | |
| Krystal Biotech Inc |
6.25%
85,000
|
$15,609,400,000 | 1.55% |
| Arcellx Inc |
7.84%
275,000
|
$15,177,250,000 | 1.51% |
| Icon Plc |
No change
45,000
|
$14,106,150,000 | 1.40% |
| Dexcom Inc |
Closed
100,000
|
$13,870,000,000 | |
| Edwards Lifesciences Corp |
Opened
150,000
|
$13,855,500,000 | 1.38% |
| Thermo Fisher Scientific Inc. |
Opened
25,000
|
$13,825,000,000 | 1.38% |
| Quest Diagnostics, Inc. |
Opened
100,000
|
$13,688,000,000 | 1.36% |
| Viking Therapeutics Inc |
44.44%
250,000
|
$13,252,500,000 | 1.32% |
| Shockwave Med Inc |
Closed
40,000
|
$13,025,200,000 | |
| Avantor, Inc. |
Closed
500,000
|
$12,785,000,000 | |
| Revolution Medicines Inc |
22.62%
325,000
|
$12,613,250,000 | 1.26% |
| AMGEN Inc. |
Opened
40,000
|
$12,498,000,000 | 1.24% |
| Cencora Inc. |
Closed
50,000
|
$12,149,500,000 | |
| Ionis Pharmaceuticals Inc |
Opened
250,000
|
$11,915,000,000 | 1.19% |
| Mckesson Corporation |
Opened
20,000
|
$11,680,800,000 | 1.16% |
| Cooper Cos Inc |
Closed
110,000
|
$11,160,600,000 | |
| Regenxbio Inc |
25.00%
950,000
|
$11,115,000,000 | 1.11% |
| Intra-Cellular Therapies Inc |
16.00%
145,000
|
$9,931,050,000 | 0.99% |
| Sanofi |
Opened
200,000
|
$9,704,000,000 | 0.97% |
| Moonlake Immunotherapeutics |
No change
220,000
|
$9,673,400,000 | 0.96% |
| Neurocrine Biosciences, Inc. |
53.33%
70,000
|
$9,636,900,000 | 0.96% |
| Teleflex Incorporated |
Opened
45,000
|
$9,464,850,000 | 0.94% |
| Alpine Immune Sciences Inc |
Closed
230,000
|
$9,117,200,000 | |
| Eli Lilly & Co |
16.67%
10,000
|
$9,053,800,000 | 0.90% |
| Apellis Pharmaceuticals Inc |
Closed
150,000
|
$8,817,000,000 | |
| Globus Med Inc |
Opened
125,000
|
$8,561,250,000 | 0.85% |
| Bruker Corp |
40.91%
130,000
|
$8,295,300,000 | 0.83% |
| Evolent Health Inc |
Closed
250,000
|
$8,197,500,000 | |
| CRISPR Therapeutics AG |
31.82%
150,000
|
$8,101,500,000 | 0.81% |
| Tandem Diabetes Care Inc |
Closed
225,000
|
$7,967,250,000 | |
| 4d Molecular Therapeutics In |
Closed
250,000
|
$7,965,000,000 | |
| Oscar Health, Inc. |
No change
500,000
|
$7,910,000,000 | 0.79% |
| Repligen Corp. |
20.00%
60,000
|
$7,563,600,000 | 0.75% |
| Denali Therapeutics Inc |
Opened
325,000
|
$7,546,500,000 | 0.75% |
| Alnylam Pharmaceuticals Inc |
Closed
50,000
|
$7,472,500,000 | |
| Macrogenics Inc |
Closed
500,000
|
$7,360,000,000 | |
| Tenaya Therapeutics Inc |
3.33%
2,325,000
|
$7,207,500,000 | 0.72% |
| Inspire Med Sys Inc |
Closed
33,000
|
$7,088,070,000 | |
| Alkermes plc |
Closed
250,000
|
$6,767,500,000 | |
| Sana Biotechnology Inc |
22.45%
1,200,000
|
$6,552,000,000 | 0.65% |
| Elanco Animal Health Inc |
18.18%
450,000
|
$6,493,500,000 | 0.65% |
| Mereo BioPharma Group plc |
86.84%
1,775,000
|
$6,390,000,000 | 0.64% |
| BeiGene Ltd |
Closed
40,000
|
$6,255,600,000 | |
| Merus N.V |
39.39%
100,000
|
$5,917,000,000 | 0.59% |
| Revvity Inc. |
Closed
50,000
|
$5,250,000,000 | |
| Insulet Corporation |
Opened
25,000
|
$5,045,000,000 | 0.50% |
| QuidelOrtho Corporation |
Opened
150,000
|
$4,983,000,000 | 0.50% |
| Align Technology, Inc. |
Closed
15,000
|
$4,918,800,000 | |
| Relay Therapeutics, Inc. |
3.45%
750,000
|
$4,890,000,000 | 0.49% |
| Surgery Partners Inc |
Opened
200,000
|
$4,758,000,000 | 0.47% |
| Natera Inc |
Closed
50,000
|
$4,573,000,000 | |
| Corbus Pharmaceuticals Hldgs |
Opened
100,000
|
$4,525,000,000 | 0.45% |
| Intuitive Surgical Inc |
80.00%
10,000
|
$4,448,500,000 | 0.44% |
| Laboratory Corp Amer Hldgs |
Closed
20,000
|
$4,369,200,000 | |
| Agilent Technologies Inc. |
Closed
30,000
|
$4,365,300,000 | |
| Catalyst Pharmaceuticals Inc |
Opened
275,000
|
$4,259,750,000 | 0.42% |
| Roivant Sciences Ltd |
33.33%
400,000
|
$4,228,000,000 | 0.42% |
| Keros Therapeutics, Inc. |
112.50%
85,000
|
$3,884,500,000 | 0.39% |
| Sage Therapeutics Inc |
Closed
200,000
|
$3,748,000,000 | |
| Hologic, Inc. |
Opened
50,000
|
$3,712,500,000 | 0.37% |
| 89bio Inc |
50.00%
450,000
|
$3,604,500,000 | 0.36% |
| Dyne Therapeutics, Inc. |
Opened
100,000
|
$3,529,000,000 | 0.35% |
| Scholar Rock Hldg Corp |
23.08%
400,000
|
$3,332,000,000 | 0.33% |
| Autolus Therapeutics plc |
Closed
500,000
|
$3,190,000,000 | |
| Cabaletta Bio Inc |
No change
425,000
|
$3,179,000,000 | 0.32% |
| Editas Medicine Inc |
50.00%
675,000
|
$3,152,250,000 | 0.31% |
| Apogee Therapeutics Inc |
100.00%
80,000
|
$3,148,000,000 | 0.31% |
| Nurix Therapeutics, Inc. |
Opened
150,000
|
$3,130,500,000 | 0.31% |
| Guardant Health Inc |
Closed
150,000
|
$3,094,500,000 | |
| Fate Therapeutics Inc |
325.00%
850,000
|
$2,788,000,000 | 0.28% |
| Neurogene Inc |
Opened
70,000
|
$2,547,300,000 | 0.25% |
| Axsome Therapeutics Inc |
Closed
30,000
|
$2,394,000,000 | |
| Spyre Therapeutics Inc |
No change
100,000
|
$2,351,000,000 | 0.23% |
| Kura Oncology Inc |
Opened
100,000
|
$2,059,000,000 | 0.20% |
| Revance Therapeutics Inc |
Opened
500,000
|
$1,285,000,000 | 0.13% |
| No transactions found | |||
| Showing first 500 out of 98 holdings | |||
Hedge funds similar to Integral Health Asset Management
- Nantahala Capital Management
- Washington Trust Bank
- Modern Wealth Management
- Rkl Wealth Management
- Altravue Capital
- United Asset Strategies
- Sir Capital Management, L.P.
- Paradigm Operations L.P.
- Good Life Advisors
- Cozad Asset Management Inc
- Pacific Life Fund Advisors
- Voss Capital, L.P.
- Onex Canada Asset Management
- Plante Moran Advisors